Omega Fund IV L.P. 13D and 13G filings for Replimune Group, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 08:35 am Sale | 2024-09-30 | 13G | Replimune Group, Inc. REPL | Omega Fund IV L.P. | 2,709,991 4.000% | -540,000 (-16.62%) | Filing |
| 2024-02-14 4:44 pm Sale | 2023-12-31 | 13G | Replimune Group, Inc. REPL | Omega Fund IV L.P. | 3,249,991 5.500% | -360,487 (-9.98%) | Filing |
| 2023-02-13 4:49 pm Sale | 2022-12-31 | 13G | Replimune Group, Inc. REPL | Omega Fund IV L.P. | 3,610,478 7.200% | -1,445,074 (-28.58%) | Filing |
| 2022-02-14 3:18 pm Sale | 2021-12-31 | 13G | Replimune Group, Inc. REPL | Omega Fund IV L.P. | 5,055,552 10.600% | -274,231 (-5.15%) | Filing |
| 2020-02-14 1:14 pm Purchase | 2019-12-31 | 13G | Replimune Group, Inc. REPL | Omega Fund IV L.P. | 5,329,783 16.500% | 226,328 (+4.43%) | Filing |